Sai Life Sciences’ IPO saw an 84% subscription rate on its first day. Institutional investors showed strong interest. The IPO aims to raise Rs 3,042 crore. The company plans to use the funds for debt repayment. Analysts are cautious due to the IPO’s high valuation. The offer includes a large OFS component. The IPO closes on December 13.
AI may hurt IT today, but it could create the sector’s next growth engine: Baroda BNP Paribas MF
AI may disrupt traditional revenue streams in India’s $280-billion IT services industry, but Rohan Korde of Baroda BNP Paribas Mutual Fund believes it could also